IRhythm Technologies Price to Free Cash Flow Ratio 2015-2024 | IRTC
Historical price to free cash flow ratio values for IRhythm Technologies (IRTC) since 2015.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| IRhythm Technologies Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-01-07 | 90.57 | 0.00 | |
| 2024-09-30 | 74.24 | $-2.34 | 0.00 |
| 2024-06-30 | 107.64 | $-3.10 | 0.00 |
| 2024-03-31 | 116.00 | $-3.66 | 0.00 |
| 2023-12-31 | 107.04 | $-2.97 | 0.00 |
| 2023-09-30 | 94.26 | $-1.82 | 0.00 |
| 2023-06-30 | 104.32 | $-1.64 | 0.00 |
| 2023-03-31 | 124.03 | $-1.56 | 0.00 |
| 2022-12-31 | 93.67 | $-1.77 | 0.00 |
| 2022-09-30 | 125.28 | $-2.55 | 0.00 |
| 2022-06-30 | 108.03 | $-2.32 | 0.00 |
| 2022-03-31 | 157.47 | $-2.17 | 0.00 |
| 2021-12-31 | 117.69 | $-2.24 | 0.00 |
| 2021-09-30 | 58.56 | $-1.45 | 0.00 |
| 2021-06-30 | 66.35 | $-1.37 | 0.00 |
| 2021-03-31 | 138.86 | $-1.60 | 0.00 |
| 2020-12-31 | 237.21 | $-0.98 | 0.00 |
| 2020-09-30 | 238.11 | $-1.83 | 0.00 |
| 2020-06-30 | 115.89 | $-2.21 | 0.00 |
| 2020-03-31 | 81.35 | $-1.86 | 0.00 |
| 2019-12-31 | 68.09 | $-1.68 | 0.00 |
| 2019-09-30 | 74.11 | $-1.27 | 0.00 |
| 2019-06-30 | 79.08 | $-1.38 | 0.00 |
| 2019-03-31 | 74.96 | $-1.59 | 0.00 |
| 2018-12-31 | 69.48 | $-1.43 | 0.00 |
| 2018-09-30 | 94.66 | $-1.39 | 0.00 |
| 2018-06-30 | 81.13 | $-1.31 | 0.00 |
| 2018-03-31 | 62.95 | $-1.09 | 0.00 |
| 2017-12-31 | 56.05 | $-0.82 | 0.00 |
| 2017-09-30 | 51.88 | $-4.28 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.799B | $0.493B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |